Leukemia

Leukemia

Astellas: A Multicenter, Open-label Treatment Protocol of gilteritinib (ASP2215) in Patients with FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) with Minimal Residual Disease (MRD)

BMCTN 1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) vs HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies (Spectrum Health Adult Bone Marrow Transplant Program)

Dana Farber 14-174: Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome

E1910: A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults

S1318: Ph II – Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Pts >/= 65 Yrs w/ Newly Diagnosed Ph- ALL and of Dasatinib, Prednisone and Blinatumomab for Patients >/= 65 Yrs w/ Newly Diagnosed Ph+ ALL

 

 

2018-03-15T07:20:23+00:00

About the Author: